Peak TRV Risk Stratification Calculator (Echocardiography Pulmonary Hypertension Assessment)

Clinical calculation support · Verify results before clinical use

Echocardiographic assessment

Enter peak tricuspid regurgitation velocity and estimated right atrial pressure.

—TRV (m/s)

Use the highest technically valid peak TRV measured by continuous-wave Doppler.

Choose the RAP estimate supported by your echocardiographic assessment. The 10 mmHg option preserves the original tool default.

—SPAP mmHg
Echocardiographic probability of PH
Enter a valid TRV
The result will appear when a valid TRV is entered.
ParameterResultNotes
Peak TRV—Continuous-wave Doppler measurement
Estimated SPAP—4 × TRV² + estimated RAP
Other PH signsNot assessedSigns in at least two categories are needed to modify probability in the ESC/ERS algorithm

SPAP is an estimate and is sensitive to RAP estimation and TRV measurement error. It is not, by itself, a diagnostic classification.

Clinical interpretation

Peak tricuspid regurgitation velocity (TRV) is used to assign echocardiographic probability of pulmonary hypertension (PH). A TRV above 2.8 m/s may suggest PH, but TRV alone cannot reliably confirm or exclude it. Interpret the result with symptoms, risk factors, and the complete echocardiogram.

How probability is assigned

  • TRV ≤2.8 m/s or unmeasurable: low probability when additional PH signs are absent; intermediate when qualifying additional signs are present.
  • TRV 2.9–3.4 m/s: intermediate probability when additional signs are absent; high when qualifying additional signs are present.
  • TRV >3.4 m/s: high echocardiographic probability.

Estimated systolic pulmonary artery pressure

SPAP = 4 × TRV² + RAP. This uses the simplified Bernoulli equation to estimate the tricuspid regurgitation pressure gradient, then adds estimated right atrial pressure. In the ESC/ERS guideline, peak TRV—not estimated SPAP—is the key variable for assigning echocardiographic probability because RAP estimation and derived pressure estimates have limitations.

Additional echocardiographic signs

Examples include RV/LV basal diameter or area ratio >1.0, septal flattening, TAPSE/SPAP ratio <0.55 mm/mmHg, RVOT acceleration time <105 ms or mid-systolic notching, pulmonary artery enlargement, and a dilated IVC with reduced inspiratory collapse or enlarged right atrial area. Signs must be present in at least two of the guideline's three categories to alter probability.

Reference

Humbert M, Kovacs G, Hoeper MM, et al.2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. European Heart Journal. 2022;43(38):3618–3731. doi:10.1093/eurheartj/ehac237.Official guideline (DOI)
Rudski LG, Lai WW, Afilalo J, et al.Guidelines for the echocardiographic assessment of the right heart in adults. Journal of the American Society of Echocardiography. 2010;23(7):685–713. doi:10.1016/j.echo.2010.05.010.
Clinical disclaimer: This calculator supports echocardiographic assessment and does not diagnose or exclude PH. Consider the complete echocardiographic findings and clinical context. Right heart catheterization is the reference method for haemodynamic confirmation when indicated by the clinical question and expected management consequences.